Skip to main content
The effectiveness of cancer treatment using particle beams such as proton beams and carbon-ion beams has been known in the field of medical physics for more than 70 years. The feature of particle therapy is to utilize the dose concentration called Bragg peak. By irradiating the lesion location with the aligned Bragg peak, the dose concentration is focused on the lesion leading to minimal side effect on the surrounding healthy tissues.
Hitachi’s Real-time image Gating system for Proton Therapy (RGPT) is an innovation that enables an accurate high dose beam delivery to moving tumors while sparing surrounding healthy tissues and organs.
Heavy-ion is said to have a better dose concentration than proton, with 2-3 times greater in killing effect on cancer cells. This effect can reduce the number of fractions and shorten the treatment period.
Hitachi provides a Hybrid particle therapy system which can irradiate both proton and carbon-ion from one accelerator.
|Corporate / Office Name
|Hitachi Australia Pty Ltd
|Suite 801, Level 8, 123, Epping Road, North Ryde NSW 2113 Australia
|+61 2 9888 4100 or 1800 HITACHI
|+61 2 9888 4188